Publication: 162

Publication: 162

C-MYC Alterations and Association With Patient Outcome in Early-Stage HER2-Positive Breast Cancer From the North Central Cancer Treatment Group N9831 Adjuvant Trastuzumab Trial

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: J Clin Oncol vol 29 (6) 651-659

Year:: 2011
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pmc-release

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:

Parents:: 64 536 648 662
Children:: None

Program:: OGC
Primary Committee:: Breast
Sec. Committees:

Pharmas:
Grants:: U24 CA114740, CA114740, R01 CA129949, CA129949, CA25224, U10 CA025224

Corr. Author:
Authors:: Edith A. Perez Robert B. Jenkins Amylou C. Dueck Anne E. Wiktor Patrick P. Bedroske S. Keith Anderson Rhett P. Ketterling William R. Sukov Kazunori Kanehira Beiyun Chen Xochiquetzal J. Geiger Cathy A. Andorfer Ann E. McCullough Nancy E. Davidson Silvana Martino George W. Sledge Peter A. Kaufman Leila A. Kutteh Julie R. Gralow Lyndsay N. Harris James N. Ingle Wilma L. Lingle Monica M. Reinholz

Networks:

Study: NCCTG-N9831
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords:: Bc5, Bc8, Original Reports, Breast Cancer